SIGA Technologies, Inc. (SIGA) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en New York City, NY, United States. El CEO actual es Diem Nguyen.
SIGA tiene fecha de IPO 1997-09-10, 46 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $336.73M.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
